Aspen Aerogels Inc (NYSE:ASPN) price on Wednesday, January 15, rose 2.00% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $12.72.
A look at the stock’s price movement, the close in the last trading session was $12.47, moving within a range at $12.65 and $13.26. The beta value (5-Year monthly) was 2.212 while the PE ratio in trailing twelve months stood at 1135.71. Turning to its 52-week performance, $33.15 and $10.75 were the 52-week high and 52-week low respectively. Overall, ASPN moved -3.27% over the past month.
Aspen Aerogels Inc’s market cap currently stands at around $1.04 billion, with investors looking forward to this quarter’s earnings report slated for in February.
Analysts have a consensus estimate of 120.83M for the company’s revenue for the quarter, with a low and high estimate of 118.8M and 123.27M respectively. The average forecast suggests up to a 43.47% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 450.44M, representing a 88.69% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ASPN is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
10 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 9 recommend ASPN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ASPN’s current price about 1.29% and -9.37% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 45.32, while 7-day volatility ratio is 5.74% and 5.60% in the 30-day chart. Further, Aspen Aerogels Inc (ASPN) has a beta value of 2.14, and an average true range (ATR) of 0.83. Analysts have given the company’s stock an average 52-week price target of $30.5, forecast between a low of $27 and high of $33. Looking at the price targets, the low is -112.26% off current price level while to achieve the yearly target high, price needs to move -159.43%. Nonetheless, investors will most likely welcome a -139.78% jump to $30.5 which is the analysts’ median price.
If we refocus on Aspen Aerogels Inc (NYSE:ASPN), historical trading data shows that trading volumes averaged 1.57 over the past 10 days and 2.39 million over the past 3 months. The company’s latest data on shares outstanding shows there are 82.05 million shares.
The 1.48% of Aspen Aerogels Inc’s shares are in the hands of company insiders while institutional holders own 85.96% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 9.82 million on 2024-12-31, giving us a short ratio of 6.12. The data shows that as of 2024-12-31 short interest in Aspen Aerogels Inc (ASPN) stood at 1604.9999 of shares outstanding, with shares short rising to 9.12 million registered in 2024-11-29. Current price change has pushed the stock 7.07% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ASPN stock continues to rise going into the next quarter.
